Melbourne company wins stem cell manufacturing licence in Australian first
A Melbourne biotechnology company has become one of the first in Australasia to receive a licence to manufacture stem cells, potentially reducing Australia’s reliance on overseas bio-tech manufacturers. The Therapeutic Goods Administration granted Magellan Stem Cells the manufacturing licence for its Braeside facility in Melbourne’s southeast, the company announced this week. The decision places Magellan…